TGFB1 and neoplasm: TGF-β signaling engages the EGFR, PDGFR, ERK and AKT/STAT pathways to stimulate cell migration (e.g., Figure 2) as well as activate alternate tumor survival pathways (e.g., elevated expression of the ABC multidrug transporters), resulting in suppression of apoptosis [130].